Early Menopause Under 45: Causes, Risks, and What to Do

Something changed and you can't put your finger on it. Your period got irregular. Sleep went sideways. Brain fog showed up at work and won't leave. Hot flashes in your late thirties. A doctor who ran your bloodwork and shrugged.

If you're under 45 and this sounds familiar, there's a good chance early menopause is what's happening. Not stress, not depression, not just "your age."

This matters beyond the symptoms. Early menopause carries real long-term health consequences: elevated cardiovascular risk, accelerated bone loss, cognitive effects, and, in some cases, questions about fertility that nobody gave you time to process. The good news is that when it's caught and managed properly, most of those risks can be substantially reduced.

Here's what's actually going on, how to confirm it, and what the options look like.

Last updated: April 2026. We review this article every 90 days.

Early Menopause, Premature Menopause, and POI: Three Different Things

Most people use these terms interchangeably. Clinicians don't, and the distinction changes the workup and the management.

Early menopause refers to menopause that occurs between ages 40 and 45. The ovaries have stopped producing estrogen permanently, periods have stopped for at least 12 consecutive months, and the process mirrors natural menopause in every way except the timing.

Premature menopause (sometimes called premature ovarian failure in older literature) means the same thing but before age 40. It's rarer (roughly 1% of women experience it [Luborsky et al., 2003]) and the causes tend to be more identifiable.

Primary ovarian insufficiency (POI) is a distinct, related condition. With POI, the ovaries still have follicles but aren't responding normally to FSH signaling. This means menstrual cycles can be irregular rather than absent, hormone levels fluctuate rather than decline steadily, and spontaneous ovulation can occasionally still occur. Women with POI have a small but real chance of conceiving without intervention. POI is diagnosed before age 40, but it lives in a different category from premature menopause. The ovary hasn't stopped permanently. It's just failing intermittently.

Why does this matter? Because if a test comes back showing elevated FSH and you're told you have "ovarian failure," you need to know whether that's POI (potentially intermittent, fertility options still exist) or true menopause (permanent). The workup and counseling diverge from there.

Understanding what's happening in your body starts with understanding what the ovary is actually doing. Early folliculogenesis (the process by which dormant follicles activate and develop) is tightly regulated by intraovarian signaling pathways (Hsueh et al., 2015). When those pathways fail, follicle development stalls, estrogen production drops, and FSH rises as the pituitary pushes harder to compensate. FSH elevation actually begins years before any clinical signs of approaching menopause, driven by declining inhibin B levels as follicle numbers fall (Burger et al., 2002).

In short: the hormonal story starts long before you notice symptoms.

Why Does Early Menopause Happen?

Early menopause has several distinct causes. Sometimes one is clearly identifiable. Sometimes it isn't.

Primary Ovarian Insufficiency (Genetic and Autoimmune)

POI accounts for a significant proportion of early menopause cases, particularly in women under 40. Genetic causes include Turner syndrome (45,X karyotype), Fragile X premutation carriers, and variants in genes involved in follicular development. Women with certain autoimmune conditions (thyroid disease, Addison's disease, rheumatoid arthritis) are at elevated risk because the immune system can mistakenly attack ovarian tissue.

Family history is among the strongest predictors. Women with an affected mother had an odds ratio of 6.1 for developing early menopause themselves, and an affected sister raised that odds ratio to 9.1. If multiple relatives were affected, the odds ratio climbed to 12.4 (Cramer et al., 1995). If your mother went through menopause in her thirties or early forties, this matters for your own timeline.

Surgical Menopause (Oophorectomy)

Bilateral oophorectomy (removal of both ovaries) causes immediate surgical menopause regardless of age. The estrogen drop is abrupt rather than gradual, which tends to produce more severe symptoms than natural menopause. Women who undergo oophorectomy for conditions like endometriosis, ovarian cysts, or as part of cancer risk reduction (BRCA mutations) face this overnight hormonal transition.

This is worth naming explicitly because surgical menopause is sometimes treated as a side note rather than a major medical event. It isn't. The abrupt estrogen withdrawal has the same long-term health implications as natural early menopause, actually more acute in the short term because there's no transition period.

Chemotherapy and Radiation

Cancer treatment is one of the most common causes of premature menopause. Childhood Cancer Survivor Study data (Sklar et al., 2006) found that the cumulative incidence of nonsurgical premature menopause was 8% in cancer survivors compared to 0.8% in control siblings, a 13-fold higher rate. Risk was tied specifically to radiation dose to the ovaries and alkylating agent chemotherapy.

Breast cancer treatment is particularly relevant here. Age and chemotherapy are the two strongest independent predictors of menopause in premenopausal women with breast cancer (Goodwin et al., 1999), and alkylating agent-based regimens (cyclophosphamide being the prime example) produced permanent amenorrhea in most women treated (Jonat et al., 2002).

For women facing cancer treatment who haven't yet completed their family, this is a conversation that needs to happen before chemotherapy begins, not after. GnRH agonists like goserelin can protect ovarian function during chemotherapy. A landmark randomized controlled trial in NEJM showed that goserelin co-administered with chemotherapy reduced ovarian failure rates from 22% to 8% (p=0.04) and also resulted in better pregnancy outcomes (Moore et al., 2015).

Idiopathic Early Menopause

Sometimes the workup is thorough and nothing comes back. No autoimmune markers, no genetic abnormality, no prior treatment. This category (idiopathic early menopause) is frustrating because there's no root cause to treat. But it's also common, and it doesn't change the management approach.

What Early Menopause Actually Feels Like

The symptoms are the same as natural menopause but earlier. That's the whole problem.

Hot flashes. Night sweats that soak through sheets. Sleep that won't consolidate. Brain fog that makes you feel like you're operating through static. Mood changes that don't respond to anything you try. Vaginal dryness. Decreased libido. Joint aches. Weight shifting toward the midsection even when nothing in your diet or exercise changed.

The specific pattern from Dr. Mary Claire Haver, board-certified OB/GYN and menopause specialist: "Females are born with all of our egg supply. At birth we have one to two million eggs. By the time we're 30, we're down to about 10% of that original supply. And by the time we're 40, we're down to 3%." When that egg reserve crosses a critical threshold, the brain's hormonal signals stop working predictably — and that's when everything starts to fluctuate.

The thing is, irregular periods are often the first sign, and they're easy to explain away. Stress. Travel. Changes in weight. It's only in retrospect that people recognize the menopause pattern earlier.

If you've been experiencing symptoms that track with low estrogen, the full picture matters. These symptoms don't exist in isolation. They compound.

The Long-Term Health Stakes

This is where early menopause becomes more than a symptom conversation. The long-term consequences are well-documented and they're significant.

The long-term consequences of premature and early menopause include adverse effects on cognition, mood, cardiovascular health, bone density, sexual function, and an increased risk of early mortality (Faubion et al., 2015). Multiple medical societies, including the North American Menopause Society, responded by recommending hormone therapy at least until the natural age of menopause for women with early estrogen deficiency.

Cardiovascular Risk

Estrogen has direct protective effects on the cardiovascular system. Earlier loss of estrogen means earlier exposure to cardiovascular risk factors.

Following 12,115 postmenopausal women for up to 20 years, each year's delay in menopause reduced cardiovascular mortality risk by 2% (Van der Schouw et al., 1996). Life expectancy for women with menopause before age 40 was 2.0 years shorter than for those with menopause after age 55 (Ossewaarde et al., 2005). Both natural and surgical premature menopause were associated with a statistically significant increased risk of incident cardiovascular disease in a JAMA study of over 244,000 women (Honigberg et al., 2019).

The Multi-Ethnic Study of Atherosclerosis (Wellons et al., 2012) found that women with early menopause before age 46 had a hazard ratio of 2.08 for coronary heart disease and stroke compared to women with normal menopause timing.

That's a roughly doubled cardiovascular risk. It's not subtle, and it starts accumulating years before women typically think of themselves as cardiac patients.

Bone Density Loss

Estrogen is central to bone maintenance. Its loss at an early age means bone density starts declining before the skeleton has had its full benefit from estrogen protection. Women with early menopause typically reach the bone density thresholds for osteopenia and osteoporosis years ahead of their peers, increasing fracture risk that compounds over decades.

Early HRT use, weight-bearing exercise, calcium, and vitamin D all matter here. The sooner bone protection starts, the more cumulative benefit.

Cognitive and Mood Effects

The brain has estrogen receptors. The relationship between estrogen and cognitive function isn't fully characterized, but early menopause is associated with measurable effects on memory and concentration. Women with POI report higher rates of mood disorders, anxiety, and difficulty with attention.

This isn't "it's all in your head." It's that the brain is a hormone-responsive organ and early estrogen deprivation has neurological consequences.

How Early Menopause Is Diagnosed

If you're under 45 and having irregular periods, night sweats, or other symptoms that don't have another explanation, these are the labs that matter.

FSH (follicle-stimulating hormone): Elevated FSH is the primary marker of declining ovarian function. A level above 25-30 IU/L on two separate occasions at least 4-6 weeks apart is the standard diagnostic threshold for POI. The "two occasions" requirement is important because FSH fluctuates, and a single elevated result can be misleading.

Estradiol (E2): Low estradiol confirms the hormonal picture. Estradiol remains relatively stable or can even rise early in the menopause transition before declining sharply in the late perimenopause (Burger et al., 2002). Isolated low estradiol without elevated FSH is less diagnostic.

AMH (anti-Müllerian hormone): AMH reflects ovarian reserve directly. It's the most stable marker across the cycle (it doesn't fluctuate with cycle day the way FSH and estradiol do). Very low AMH in a woman under 40 is a sensitive indicator of diminished ovarian reserve. By age 40, most women retain only 3% of their maximum pre-birth follicle population (Wallace et al., 2009). AMH quantifies how far along that decline has gone.

Repeat testing: The FSH result especially needs to be repeated. Perimenopause produces chaotic hormone fluctuations, and a single test taken at the wrong point can produce misleading results in either direction. If you get a result that doesn't fit your symptoms, push for a repeat draw at the right cycle day (day 2-5 of a cycle, if cycling).

Additional workup: For women under 40, the evaluation expands to include karyotyping (to check for Turner syndrome or other chromosomal abnormalities), Fragile X premutation testing, thyroid function, and adrenal antibodies. These aren't always standard in the first visit, so ask for them.

For context on what a full hormonal workup looks like, HEXIS providers start with a complete panel that includes these markers rather than selective testing.

Hormone Replacement Therapy: The Standard of Care

HRT for early menopause is not the same conversation as HRT for natural menopause at 51. The risk-benefit calculation is different, and it leans much more clearly toward treatment.

Hormone replacement therapy is the standard of care for women with POI and early menopause, recommended until at least the natural age of menopause (around 51) (Sullivan et al., 2016). Without it, women carry decades of unnecessary cardiovascular and bone risk.

The landmark WHI study (the one that scared a generation of physicians and patients away from HRT) enrolled women with a mean age of 63. Its risks don't apply to women in their thirties and forties using HRT to replace estrogen they should still naturally have. This distinction matters, and it's been poorly communicated.

What HRT typically looks like for early menopause:

• Estradiol: Usually transdermal (patch, gel, or spray) rather than oral. Transdermal delivery avoids first-pass liver metabolism and is associated with lower clotting risk. Doses for young women with early menopause are typically higher than those used for older postmenopausal women because the goal is to approximate the estrogen levels a woman her age would naturally have.
• Progesterone (for women with an intact uterus): Required to protect the uterine lining. Micronized progesterone is generally preferred.
• Testosterone: Often forgotten, often needed. Women produce testosterone from the ovaries. Early menopause means earlier testosterone loss as well, and this affects libido, energy, and mood. Some providers add low-dose testosterone to an HRT protocol; ask about it specifically.

Individualization matters here. Higher estrogen doses may be needed in younger women to approximate physiological concentrations (Faubion et al., 2015). There isn't a one-size protocol here.

The perimenopause symptoms and treatment article covers HRT options in more detail for women in the transition phase, though the principles for early menopause follow the same foundation.

Fertility After Early Menopause

The fertility picture depends on whether you have true early menopause or POI.

With true early menopause, spontaneous conception is not possible. But if eggs were frozen before the diagnosis, IVF with those frozen eggs remains an option. Donor egg IVF is also available and has high success rates — the uterus of a woman with early menopause is typically still functional with hormone support.

With POI, the situation is more nuanced. Because ovulation can occasionally still occur, pregnancy is not impossible, though it's unpredictable and not reliable. Women with POI who want to conceive should work with a reproductive endocrinologist, not just a generalist.

Fertility preservation before cancer treatment is increasingly standard. If chemotherapy is planned, this is the conversation to have urgently — before the first dose, not after. Egg freezing, embryo freezing, and ovarian tissue cryopreservation are all options, with varying evidence bases and success rates depending on age and timeline. GnRH agonist co-treatment (as in the Moore et al., 2015 NEJM trial) may help protect ovarian function during treatment, but it isn't a guarantee and doesn't replace fertility preservation.

What to Do About Bone Health Specifically

Because the bone consequences of early estrogen loss are both serious and preventable, this deserves specific attention beyond the general HRT recommendation.

HRT itself is protective. Estrogen preserves bone density. Starting HRT early in the course of early menopause reduces the rate of bone loss substantially.

Weight-bearing exercise matters more than cardio. Running, lifting, climbing stairs (activities that put mechanical load through bone) stimulate bone formation. Resistance training is particularly effective. This isn't a secondary consideration; for women with early menopause, it's a primary intervention.

Calcium and vitamin D. Calcium from food first (dairy, fortified foods, leafy greens), supplemented to reach the daily target. Vitamin D in the 2,000-4,000 IU range is commonly recommended for women at risk for bone loss, but labs should guide the dose.

DEXA scan. A baseline bone density scan at diagnosis and periodic monitoring gives you and your provider concrete data to track.

The menopause symptoms complete list covers bone and joint symptoms in the context of the broader symptom picture.

The Cost and Access Conversation

HRT for early menopause isn't a lifestyle choice. It's hormone replacement for a deficiency. Most physicians treating early menopause will prescribe it, though access varies.

Insurance coverage: Many insurance plans cover FDA-approved hormone therapies (oral estradiol, estradiol patches, progesterone) when prescribed with an appropriate diagnosis code. Prior authorization is common. Compounded bioidentical hormones are typically not covered and run $50-150/month out of pocket depending on formulation.

HEXIS approach: HEXIS providers start with a full hormone panel that includes estradiol, FSH, AMH, and testosterone. Your HRT protocol is built from those numbers, not from a template. For women in Montana, Idaho, Washington, and Oregon, telehealth consultations are available. For Great Falls, MT patients, in-clinic evaluation and follow-up are options.

A Schedule a consultation gives you access to a physician who will run the right labs and build a protocol around your actual hormone levels, not just manage symptoms.

Working With HEXIS on Early Menopause

Early menopause is a medical condition with real, measurable health consequences. It's also manageable when it's caught and when the treatment is individualized.

HEXIS providers approach this with labs first, not assumptions. If your early menopause is confirmed, we build your HRT protocol around your specific estradiol, FSH, AMH, and testosterone numbers. We monitor bone density, cardiovascular markers, and symptom response over time. If fertility questions are part of the picture, we coordinate with reproductive endocrinology.

You shouldn't be piecing this together alone from Reddit and podcast clips. If you're under 45 and your hormones don't feel right, schedule a consultation and let's look at the actual numbers.